Fennec Pharmaceuticals (FRX) Stock Chart & Stock Price History → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free FRX Stock Alerts C$10.04 -3.68 (-26.82%) (As of 03:52 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Fennec Pharmaceuticals Stock Price Performance5 Day PerformanceN/A1 Month Performance-29.78%3 Month Performance-22.18%6 Month PerformanceN/AYear-To-Date Performance-32.65%1 Year Performance+1.59% Receive FRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. FRX Stock Chart for Tuesday, May, 14, 2024 FRX Chart by TradingView Fennec Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024C$13.47C$13.72+1.86%C$13.72C$13.66210 shsC$371.81 million05/10/2024C$12.65C$13.47+6.48%C$13.47C$13.47250 shsC$365.04 million05/08/2024C$12.65C$12.65C$12.65C$12.46800 shsC$342.82 million05/07/2024C$12.50C$12.65+1.20%C$12.65C$12.46800 shsC$342.82 million05/06/2024C$12.58C$12.50-0.64%C$12.50C$12.50100 shsC$338.75 million05/01/2024C$12.58C$12.58C$12.61C$12.58602 shsC$340.92 million Get the Latest News and Ratings for FRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024C$12.58C$12.58C$12.61C$12.58602 shsC$340.16 million04/29/2024C$12.58C$12.58C$12.61C$12.58602 shsC$340.16 million04/26/2024C$12.80C$12.58-1.72%C$12.61C$12.58602 shsC$340.16 million04/23/2024C$12.80C$12.80C$12.81C$12.75800 shsC$346.11 million04/22/2024C$12.82C$12.80-0.16%C$12.81C$12.75800 shsC$346.11 million04/19/2024C$13.77C$12.82-6.90%C$12.82C$12.81400 shsC$346.65 million04/18/2024C$13.77C$13.77C$13.77C$13.77200 shsC$372.34 million04/17/2024C$14.32C$13.77-3.84%C$13.77C$13.77200 shsC$372.34 million04/16/2024C$14.20C$14.32+0.85%C$14.32C$14.31300 shsC$387.21 million04/15/2024C$14.54C$14.20-2.34%C$14.20C$14.20100 shsC$383.97 million04/12/2024C$14.54C$14.54C$14.54C$14.54610 shsC$393.16 million04/11/2024C$14.53C$14.54+0.07%C$14.54C$14.54610 shsC$393.16 million04/10/2024C$14.67C$14.53-0.95%C$14.54C$14.53600 shsC$392.89 million04/09/2024C$15.00C$14.67-2.20%C$14.67C$14.59200 shsC$396.68 million04/05/2024C$15.00C$15.00C$15.00C$15.00100 shsC$405.60 million04/04/2024C$15.04C$15.00-0.27%C$15.00C$15.00121 shsC$405.60 million04/03/2024C$15.04C$15.04C$15.04C$14.97200 shsC$406.68 million04/02/2024C$15.10C$15.04-0.40%C$15.04C$14.97200 shsC$406.68 million04/01/2024C$15.10C$15.10C$15.10C$15.10100 shsC$408.30 million03/29/2024C$15.10C$15.10C$15.10C$15.10100 shsC$408.30 million03/28/2024C$14.81C$15.10+1.96%C$15.10C$15.10100 shsC$408.30 million03/27/2024C$14.81C$14.81C$14.81C$14.81500 shsC$400.46 million03/26/2024C$15.20C$14.81-2.57%C$14.81C$14.81515 shsC$400.46 million03/25/2024C$13.18C$15.20+15.33%C$15.20C$14.663,400 shsC$411.01 million03/20/2024C$13.18C$13.18C$13.18C$13.18100 shsC$352.04 million03/19/2024C$13.18C$13.18C$13.18C$13.18188 shsC$352.04 million03/18/2024C$13.18C$13.18C$13.18C$13.18188 shsC$352.04 million03/15/2024C$13.18C$13.18C$13.18C$13.18190 shsC$352.04 million03/14/2024C$13.18C$13.18C$13.19C$13.18302 shsC$352.04 million03/13/2024C$12.80C$13.18+2.97%C$13.19C$13.18302 shsC$352.04 million03/12/2024C$13.20C$12.80-3.03%C$12.80C$12.80100 shsC$341.89 million03/11/2024C$13.20C$13.20C$13.46C$12.87300 shsC$352.57 million03/08/2024C$12.86C$13.20+2.64%C$13.46C$12.87300 shsC$352.57 million03/07/2024C$13.12C$12.86-1.98%C$13.12C$12.861,600 shsC$343.49 millionInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a Century (Ad)Starpax’s technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible.Invest today03/06/2024C$12.89C$13.12+1.78%C$13.12C$12.87350 shsC$350.44 million03/01/2024C$12.89C$12.89C$12.89C$12.89200 shsC$344.29 million02/29/2024C$12.45C$12.89+3.53%C$12.89C$12.89220 shsC$344.29 million02/28/2024C$12.45C$12.45C$12.45C$12.18500 shsC$332.54 million02/27/2024C$12.02C$12.45+3.58%C$12.45C$12.18500 shsC$332.54 million02/21/2024C$12.02C$12.02C$12.02C$12.02100 shsC$321.05 million02/20/2024C$12.28C$12.02-2.12%C$12.02C$12.02100 shsC$321.05 million02/16/2024C$12.28C$12.28C$12.37C$12.21800 shsC$328.00 million02/15/2024C$13.12C$12.28-6.40%C$12.37C$12.21800 shsC$328.00 million02/14/2024C$13.12C$13.12C$13.52C$13.123,600 shsC$350.44 million02/13/2024C$13.40C$13.12-2.09%C$13.52C$13.123,621 shsC$350.44 million Related Companies: MDNA Stock Chart ONC Stock Chart SVA Stock Chart KSI Stock Chart OPS Stock Chart VMD Stock Chart VHI Stock Chart DR Stock Chart OGI Stock Chart QIPT Stock Chart Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:FRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.